Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 5
1992 3
1993 2
1994 2
1995 3
1996 2
1997 2
1998 7
1999 4
2000 3
2001 3
2002 9
2003 5
2004 4
2005 8
2006 16
2007 16
2008 21
2009 21
2010 25
2011 29
2012 19
2013 30
2014 21
2015 33
2016 31
2017 17
2018 4
2019 5
2020 7
2021 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

325 results
Results by year
Filters applied: . Clear all
Page 1
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guénel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menéndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Brüning T, Ko YD, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K; Australian Ovarian Cancer Study Group; Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnæs GG, Zhe… See abstract for full author list ➔ Southey MC, et al. Among authors: massuger lf. J Med Genet. 2016 Dec;53(12):800-811. doi: 10.1136/jmedgenet-2016-103839. Epub 2016 Sep 5. J Med Genet. 2016. PMID: 27595995 Free PMC article.
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.
Van der Meer JMR, Maas RJA, Guldevall K, Klarenaar K, de Jonge PKJD, Evert JSH, van der Waart AB, Cany J, Safrit JT, Lee JH, Wagena E, Friedl P, Önfelt B, Massuger LF, Schaap NPM, Jansen JH, Hobo W, Dolstra H. Van der Meer JMR, et al. Among authors: massuger lf. Cancer Immunol Immunother. 2021 May;70(5):1305-1321. doi: 10.1007/s00262-020-02749-8. Epub 2020 Nov 3. Cancer Immunol Immunother. 2021. PMID: 33140189 Free PMC article.
In reply.
Bosgraaf RP, Mast PP, Struik-van der Zanden PH, Bulten J, Massuger LF, Bekkers RL. Bosgraaf RP, et al. Among authors: massuger lf. Obstet Gynecol. 2013 Dec;122(6):1304-5. doi: 10.1097/AOG.0000000000000031. Obstet Gynecol. 2013. PMID: 24264702 No abstract available.
[Trophoblastic diseases].
ten Kate-Booij MJ, Lok CA, Verheijen RH, Massuger LF, van Trommel NE. ten Kate-Booij MJ, et al. Among authors: massuger lf. Ned Tijdschr Geneeskd. 2008 Oct 11;152(41):2219-24. Ned Tijdschr Geneeskd. 2008. PMID: 19009808 Review. Dutch.
Clinical management of uterine papillary serous carcinoma.
Roelofsen T, van Ham MA, de Hullu JA, Massuger LF. Roelofsen T, et al. Among authors: massuger lf. Expert Rev Anticancer Ther. 2011 Jan;11(1):71-81. doi: 10.1586/era.10.199. Expert Rev Anticancer Ther. 2011. PMID: 21166512 Review.
[Familial history of ovarian carcinoma: policy].
de Hullu JA, Kets CM, Massuger LF, Ligtenberg ML, van Ham MA, Hoogerbrugge N. de Hullu JA, et al. Among authors: massuger lf. Ned Tijdschr Geneeskd. 2011;155:A2392. Ned Tijdschr Geneeskd. 2011. PMID: 21262027 Review. Dutch.
BRCA1/2 mutation carriers are potentially at higher cardiovascular risk.
Arts-de Jong M, Maas AH, Massuger LF, Hoogerbrugge N, de Hullu JA. Arts-de Jong M, et al. Among authors: massuger lf. Crit Rev Oncol Hematol. 2014 Aug;91(2):159-71. doi: 10.1016/j.critrevonc.2014.01.008. Epub 2014 Jan 24. Crit Rev Oncol Hematol. 2014. PMID: 24529552 Review.
The current position and the future perspectives of cervical cancer screening.
Bosgraaf RP, Siebers AG, De Hullu JA, Massuger LF, Bulten J, Bekkers RL, Melchers WJ. Bosgraaf RP, et al. Among authors: massuger lf. Expert Rev Anticancer Ther. 2014 Jan;14(1):75-92. doi: 10.1586/14737140.2014.856273. Epub 2013 Nov 28. Expert Rev Anticancer Ther. 2014. PMID: 24308681 Review.
Triage of high-risk HPV positive women in cervical cancer screening.
Ebisch RM, Siebers AG, Bosgraaf RP, Massuger LF, Bekkers RL, Melchers WJ. Ebisch RM, et al. Among authors: massuger lf. Expert Rev Anticancer Ther. 2016 Oct;16(10):1073-85. doi: 10.1080/14737140.2016.1232166. Epub 2016 Sep 12. Expert Rev Anticancer Ther. 2016. PMID: 27598683 Review.
325 results